Medicare Enrolled
Dr. Ashraf Hanna
Pain Medicine · Clearwater, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hanna from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hanna? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Hanna
Dr. Ashraf Hanna is a pain medicine in Clearwater, FL, with 20 years in practice. Based on federal Medicare data, Dr. Hanna performed 49,315 Medicare services across 5,170 unique beneficiaries.
Between the years covered by Open Payments, Dr. Hanna received a total of $16,669 from 67 pharmaceutical and/or device companies across 1024 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hanna is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 2% volume in FL$ $16,669 industry payments
Medicare Practice Summary
Medicare Utilization ↗49,315
Medicare services
Top 2% in FL for pain medicine
5,170
Unique beneficiaries
$19
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,466 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, lidocaine hcl for intravenous infusion, 10 mg | 13,550 | $0 | $0 |
| Botox injection, per unit | 8,900 | $5 | $40 |
| Unclassified drugs | 4,499 | $0 | $49 |
| Anti-nausea injection (ondansetron/Zofran) | 3,372 | $0 | $25 |
| Office visit, established patient (30-39 min) | 2,749 | $91 | $645 |
| Office visit, established patient (20-29 min) | 1,809 | $67 | $437 |
| Injection of additional new drug or substance into vein | 1,770 | $12 | $132 |
| Injection, midazolam hydrochloride, per 1 mg | 1,370 | $0 | $25 |
| Injection, magnesium sulfate, per 500 mg | 1,268 | $0 | $0 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 1,096 | $16 | $63 |
| Injection into tendon or ligament | 868 | $45 | $356 |
| Betamethasone steroid injection | 822 | $5 | $35 |
| Evaluation of psychological test, first hour | 601 | $91 | $250 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 566 | $193 | $1,245 |
| Infusion, normal saline solution, 250 cc | 523 | $0 | $100 |
| Smoking and tobacco use intensive counseling, 4-10 minutes | 516 | $14 | $100 |
| Ultrasonic guidance for needle placement | 484 | $45 | $439 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 416 | $48 | $213 |
| Injection of drug or substance into vein | 416 | $28 | $335 |
| Electrocardiogram (ecg) 1 to 3 leads | 405 | $5 | $18 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 362 | $59 | $1,062 |
| Testing for presence of drug, read by direct observation | 322 | $12 | $89 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 287 | $25 | $480 |
| Injection of trigger points, 1-2 muscles | 221 | $28 | $335 |
| Destruction of peripheral nerve or branch | 215 | $47 | $804 |
| Joint injection, major joint | 173 | $52 | $369 |
| Injection, promethazine hcl, up to 50 mg | 167 | $2 | $5 |
| New patient office visit (45-59 min) | 164 | $122 | $1,000 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 155 | $187 | $2,574 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 154 | $106 | $1,051 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 146 | $61 | $528 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | 142 | $54 | $1,178 |
| Injection, diphenhydramine hcl, up to 50 mg | 133 | $1 | $5 |
| Destruction of nerves supplying joint between spine and pelvis using imaging guidance | 79 | $224 | $1,216 |
| Drug injection, under skin or into muscle | 69 | $11 | $147 |
| Injection of substance into lower spine canal using imaging guidance | 63 | $78 | $641 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | 55 | $152 | $2,611 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 52 | $129 | $915 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 51 | $100 | $1,333 |
| Dexamethasone injection (steroid) | 45 | $0 | $50 |
| Injection of upper or middle spine facet joint using imaging guidance, single level | 40 | $121 | $1,169 |
| Injection of upper or middle spine facet joint using imaging guidance, second level | 38 | $70 | $577 |
| Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | 36 | $166 | $776 |
| Injection of substance into middle or upper spine canal using imaging guidance | 27 | $80 | $659 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 26 | $157 | $1,245 |
| Injection of trigger points, 3 or more muscles | 23 | $30 | $386 |
| Injection of anesthetic agent and/or steroid into upper neck and back of head nerve | 19 | $68 | $616 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 18 | $92 | $979 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 18 | $42 | $534 |
| Aspiration and/or injection of fluid from medium joint | 15 | $38 | $306 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
31.6% high complexity
43.3% medium
25.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$16,669
Total received (2018-2024)
Avg $2,381/year across 7 years
Top 9% in FL for pain medicine
67
Companies
1,024
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,544 (99.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$125 (0.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,819
2023$1,834
2022$2,283
2021$2,311
2020$2,058
2019$2,268
2018$3,096
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Collegium Pharmaceutical, Inc.
$1,825
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,256
Supernus Pharmaceuticals, Inc.
$1,049
Boston Scientific Corporation
$916
PFIZER INC.
$905
Nevro Corp.
$785
Abbott Laboratories
$720
SCILEX PHARMACEUTICALS INC.
$621
ABBVIE INC.
$509
PROTEGA PHARMACEUTIALS INC
$443
Scilex Pharmaceuticals Inc.
$411
Eisai Inc.
$362
Lilly USA, LLC
$358
Allergan, Inc.
$351
RedHill Biopharma Inc.
$326
Novartis Pharmaceuticals Corporation
$326
Biohaven Pharmaceuticals, Inc.
$304
Azurity Pharmaceuticals, Inc.
$302
Biohaven Pharmaceutical Holding Company Ltd.
$271
AbbVie Inc.
$269
Daiichi Sankyo Inc.
$260
US WorldMeds, LLC
$258
Amgen Inc.
$257
Horizon Therapeutics plc
$247
IDORSIA PHARMACEUTICALS US INC
$233
Stimwave Technologies Incorporated
$227
Egalet US Inc
$214
Horizon Pharma plc
$166
Avanir Pharmaceuticals, Inc.
$159
Zyla Life Sciences
$157
Pernix Therapeutics Holdings, Inc.
$152
Kowa Pharmaceuticals America, Inc.
$137
Zyla Life Sciences, Inc.
$134
Indivior Inc.
$125
Almatica Pharma LLC
$121
BioDelivery Sciences International, Inc.
$118
IMPEL PHARMACEUTICALS INC.
$108
Teva Pharmaceuticals USA, Inc.
$107
USWM, LLC
$99
Currax Pharmaceuticals LLC
$96
ARBOR PHARMACEUTICALS, INC.
$93
INTRA-SANA LABORATORIES
$85
Takeda Pharmaceuticals U.S.A., Inc.
$73
Upsher-Smith Laboratories LLC
$62
IBSA Pharma Inc.
$59
PROTEGA PHARMACEUTIALS LLC
$55
Kaleo, Inc.
$50
Hikma Pharmaceuticals USA
$49
AstraZeneca Pharmaceuticals LP
$47
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$41
Bioventus LLC
$41
Arbor Pharmaceuticals, Inc.
$37
BOSTON SCIENTIFIC CORPORATION
$29
Assertio Therapeutics, Inc.
$28
UPSHER-SMITH LABORATORIES LLC
$26
Purdue Pharma L.P.
$26
Relievant Medsystems, Inc.
$24
EISAI INC.
$23
SI-BONE, INC.
$20
Allergan Inc.
$19
NeuroMetrix Inc
$16
Shionogi Inc
$16
Fidia Pharma USA Inc.
$15
Nuvectra Corporation
$15
Medtronic, Inc.
$13
Medtronic USA, Inc.
$12
FIDIA PHARMA USA INC.
$10
Top 3 companies account for 24.8% of total payments
Associated products mentioned in payments ›
AIMOVIG · AJOVY · ARYMO ER · Aimovig · Algovita · Amitiza · BELBUCA · BOTOX · BUNAVAIL 2.1 mg 30-count box · Belbuca · CHANTIX · COMIRNATY · CONTRAVE · DUEXIS · Dayvigo · Durolane · EMGALITY · Evzio · GENERAL PAIN MANAGEMENT · GRALISE · HORIZANT · HYMOVIS · Horizant · Hymovis · INTELLIS · Intracept · Kloxxado · LUCEMYRA · LYRICA · Licart · Lucemyra · Lucemyra/Lofexidine · MOVANTIK · Morphabond ER · Motegrity · Movantik · NURTEC ODT · ONZETRA Xsail · OXAYDO · OXTELLAR XR · OXYCONTIN · Octrode SCS Leads · Omnia · PAXLOVID · PENNSAID · PROCLAIM · Proclaim Family of SCS IPGs · Proclaim IPG · Prodigy Family of SCS IPGs · QULIPTA · QUVIVIQ · RELISTOR · RELISTOR ORAL · RELTONE 200 MG · ROXYBOND · Roxybond · SEGLENTIS · SPECTRA WAVEWRITER · SPRIX · SUBOXONE SUBLINGUAL FILM · SYMJEPI · SYMPROIC · Senza · Senza Spinal Cord Stimulation System · Stimrouter Implantable Kit · Symproic · TOSYMRA SUMATRIPTAN NASAL SPRAY · TREXIMET · TROKENDI XR · Tirosint · Trudhesa · UBRELVY · VIMOVO · WAVEWRITER ALPHA · WaveWriter Alpha Prime 16 · XTAMPZA · XTAMPZAER · Xtampza ER · XtampzaER · ZAVZPRET · ZEMBRACE SYMTOUCH · ZIPSOR · ZOHYDRO ER · ZORVOLEX · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for pain medicine in FL.
Equivalent to $34 per 100 Medicare services performed
Geographic Context
Pain Medicines within 10 mi
14
Per 100K population
1.5
County median income
$70,293
Nearest hospital
WINDMOOR HEALTHCARE OF CLEARWATER
2.6 mi
2.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Hanna is a mixed practice specialist, with above-average Medicare volume (top 2% in FL), and high industry engagement (low-engagement, top 9%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Hanna experienced with injection, lidocaine hcl for intravenous infusion, 10 mg?
Based on Medicare claims data, Dr. Hanna performed 13,550 injection, lidocaine hcl for intravenous infusion, 10 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hanna receive payments from pharmaceutical companies?
Yes. Dr. Hanna received a total of $16,669 from 67 companies across 1,024 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hanna's costs compare to other pain medicines in Clearwater?
Dr. Hanna's average Medicare payment per service is $19. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hanna) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Pain Medicines in Clearwater
Browse pain medicines in Clearwater ranked by procedure volume and transparency data.
Highest volume
Top Pain Medicines in FL
Pain Medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pain Medicines in FL
Which FL pain medicines receive the most from drug and device companies.
By company
Collegium Pharmaceutical, Inc. Payments to Doctors
See all physicians who received payments from Collegium Pharmaceutical, Inc..
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
By company
Supernus Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Supernus Pharmaceuticals, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology